Tuttle Capital Management’s Boston Scientific BSX Stock Holding History

Tuttle Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-7,356	Closed	-$314K	–	114
2019 Q3	$314K	Sell	7,356 -40,671	-85%	-$1.72M	0.08%	187
2019 Q2	$2.06M	Buy	+48,027	New	+$1.85M	0.81%	37
2019 Q1	–	Sell	-19,900	Closed	-$703K	–	173
2018 Q4	$703K	Sell	19,900 -63,400	-76%	-$2.3M	0.27%	74
2018 Q3	$3.21M	Buy	+83,300	New	+$2.91M	0.61%	47

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Tuttle Capital Management's BSX Position: Q4 2019 in Review

Tuttle Capital Management sold out of Boston Scientific (BSX) in Q4 2019, closing a stake of 7,356 shares — an estimated $314K sold.

Tuttle Capital Management first reported a position in BSX in Q3 2018 and held it in 4 quarters. The position peaked at $3.21M in Q3 2018. 853 funds tracked by Wall St. Rank hold BSX as of Q4 2019.

Tuttle Capital Management reported no remaining Boston Scientific position as of Q4 2019 after selling out during the quarter.
Tuttle Capital Management sold 7,356 Boston Scientific shares in Q4 2019, an estimated $314K.
Tuttle Capital Management first reported a position in Boston Scientific in Q3 2018 and held it in 4 quarters.
Tuttle Capital Management's Boston Scientific position peaked at $3.21M in Q3 2018.
853 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2019.

Based on Tuttle Capital Management's 13F filing for Q4 2019, filed 13 Jan 2020.